LABP
Landos Biopharma, Inc. Common Stock
LABP
LABP
Delisted
LABP was delisted on the 23rd of May, 2024.
23 hedge funds and large institutions have $7.87M invested in Landos Biopharma, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$26K | |
| 2 | +$10.5K | |
| 3 | +$7.41K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.33K |
| 5 |
SGCA
Steel Grove Capital Advisors
Memphis,
Tennessee
|
+$5K |
Top Sellers
| 1 | -$2.58M | |
| 2 | -$804K | |
| 3 | -$136K | |
| 4 |
AI
ArchPoint Investors
Coral Gables,
Florida
|
-$83K |
| 5 |
Renaissance Technologies
New York
|
-$67K |